Article Data

  • Views 2103
  • Dowloads 195

Original Research

Open Access

The Value of Urine NAG, NGAL Combined with Serum Cys-C in Early Diagnosis of Neonatal Hyperbilirubinemia-related Acute Kidney Injury

  • Zhen Wang1
  • Lv Jin1
  • Tao Shen1
  • Shihong Zhan2

1Department of Neonatology, Suzhou integrated hospital of traditional Chinese and Western Medicine, P. R. China

2Department of Neonatology, Children’s Hospital of Soochow University, P. R. China

DOI: 10.22514/sv.2020.16.0055 Vol.16,Issue 2,October 2020 pp.109-113

Published: 28 October 2020

*Corresponding Author(s): Shihong Zhan E-mail:


Objective: To explore the early diagnostic value of urinary NAG, NGAL and serum Cys-C detection for neonatal hyperbilirubinemia-related acute kidney injury (AKI) in full-term neonates with hyperbilirubinemia. Methodology: One hundred and ninety-six full-term jaundiced newborns were categorized as mild (n = 65), moderate (n = 69) or severe hyperbilirubinemia (n = 62). The severe group was divided into a non-AKI group (n = 35) and an AKI group (n = 27). Sixty-five full-term newborns with normal serum bilirubin and renal function were analyzed as a normal control group. Urine NAG, urine NGAL and serum Cys-C weremeasured. The value of urinary NAG, NGAL combined with serum Cys-C in early diagnosis of neonatal hyperbilirubinemia-related AKI was evaluated by Receiver Operating Characteristic Curve (ROC). Result: Levels of urine NAG, NGAL and serum Cys-C in the mild, moderateand severe groups were higher than those in the normal control group (p < 0.001), the above indexes levels in the severe group were higher than those in the mildand moderate groups (p < 0.001), and the above indexes levels in the moderate group were higher than those in the mild group (p < 0.001). Pearson correlation analysis showed that serum Cys-C was positively correlated with urinary NAG and urinary NGAL in AKI group (r = 0.805, p < 0.001; r = 0.864, p < 0.001); there was a positive correlation between urinary NAG and urinary NGAL in AKI group (r = 0.948, p < 0.001). AUC of urinary NAG, urinary NGAL combined with serum Cys-C in diagnosing neonatal hyperbilirubinemia-related AKI is 0.900 (95%CI: 0.824-0.976), which is higher than that of urinary NAG, urinary NGAL and serum Cys-C alone. Conclusion: Combined measurement of urine NAG, NGAL and serum Cys-C is helpful for early diagnosis of neonatal hyperbilirubinemia-related AKI.


N-Acetyl-β-D-glucosaminidase (NAG), Neutrophil gelatinase-associated lipid carrier protein (NGAL), Cysteine protease inhibitor C (Cys-C), Hyperbiliubinemia, Acute kidney injury (AKI), Newborn

Cite and Share

Zhen Wang,Lv Jin,Tao Shen,Shihong Zhan. The Value of Urine NAG, NGAL Combined with Serum Cys-C in Early Diagnosis of Neonatal Hyperbilirubinemia-related Acute Kidney Injury. Signa Vitae. 2020. 16(2);109-113.


[1] Shan KH, Wang TM, Lin MC. Association between rooming-in policy and neonatal hyperbilirubinemia. Pediatr Neonatol. 2019;60:186-191.

[2] Bhardwaj K, Locke T, Biringer A, et al. Newborn Bilirubin Screening for Preventing Severe Hyperbilirubinemia and Bilirubin Encephalopathy: A Rapid Review. Curr Pediatr Rev. 2017;13:67-90.

[3] Bech LF, Donneborg ML, Lund AM, et al. Extreme neonatal hyper-bilirubinemia, acute bilirubin encephalopathy, and kernicterus spectrum disorder in children with galactosemia. Pediatr Res. 2018;84:228-232.

[4] Rafat C, Burbach M, Brochériou I, et al. Bilirubin-Associated Acute Tubular Necrosis in a Kidney Transplant Recipient. Am J Kidney Dis. 2013;61:782-785.

[5] Wu YH, Wu CY, Cheng CY, et al. Severe Hyperbilirubinemia Is Associated With Higher Risk of Contrast-Related Acute Kidney Injury Following Contrast-Enhanced Computed Tomography. PLoS One. 2020;15:e0231264.

[6] Durkan AM, Alexander RT. Acute Kidney Injury Post Neonatal Asphyxia. J Pediatr. 2011;158:e29-33.

[7] Srichai MB, Hao C, Davis L, et al. Apoptosis of the Thick Ascending Limb Results in Acute Kidney Injury. J AM Soc Nephrol. 2008;19:1538-1546.

[8] Skálová S. The Diagnostic Role of Urinary N-acetyl-beta-D-glucosaminidase (NAG) Activity in the Detection of Renal Tubular Impairment. Acta Medica (Hradec Kralove). 2005;48:75-80.

[9] Kim YD, Yim DH, Eom SY, et al. Temporal Changes in Urinary Levels of Cadmium, N-acetyl-β-d-glucosaminidase and β2-microglobulin in Indi-viduals in a Cadmium-Contaminated Area. Environ Toxicol Pharmacol. 2015;39:35-41.

[10] Cheng B, Jin Y, Liu G, et al. Urinary N-acetyl-beta-D-glucosaminidase as an early marker for acute kidney injury in full-term newborns with neonatal hyperbilirubinemia. Dis Markers. 2014;2014:315843.

[11] Gong L, Yu H, Zhu Ge Y, et al. Neutrophil Gelatinase-Associated Lipocalin Protects Renal Tubular Epithelial Cell in ischemic/reperfusion Injury Rats via Apoptosis-Regulating Proteins. Ren Fail. 2012;34:777-783.

[12] Segawa H, Hatta T, Kawasaki Y, et al. The utility of urinary NGAL (neutrophil gelatinase-associated lipocalin) as a prognostic marker for initiating acute hemoperfusion therapy. Nihon Toseki Igakkai Zasshi. 2014;47:487-491.

[13] Sjöström P, Tidman M, Jones I. Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest. 2005;65:111-124.

[14] Bagshaw SM, Bellomo R. Cystatin C in Acute Kidney Injury. Curr Opin Crit Care. 2010;16:533-539.

[15] Kari JA, Shalaby MA, Sofyani K, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) and serum cystatin C measurements for early diagnosis of acute kidney injury in children admitted to PICU. World J Pediatr. 2018;14:134-142.

[16] Khwaja A. KDIGO clinical practice guidelines for acutekidney injury. Nephron Clin Pract. 2012;120:c179-184.

[17] Ding G, Pu M. Recommendations intervention for neonatal jaundice. Chin J paediatr. 2001;39:185-187.

[18] Lund HT, Jacobsen J. Influence of Phototherapy on Unconjugated Bilirubin in Duodenal Bile of Newborn Infants With Hyperbilirubinemia. Acta Paediatr Scand. 1972;61:693-696.

[19] Ahlfors CE, Wennberg RP, Ostrow JD, et al. Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice. Clin Chem. 2009;55:1288-1299.

[20] Edelstein CL. Biomarkers in Acute Kidney Injury. Biomarkers of Kidney Disease (Second edition). 2017. p. 241-315.

[21] Kiyosue A, Hirata Y, Ando J, et al. Plasma Cystatin C Concentration Reflects the Severity of Coronary Artery Disease in Patients Without Chronic Kidney Disease. Circ J. 2010;74:2441-2447.

[22] Bosomworth MP, Aparicio SR, Hay AW. Urine N-acetyl-beta-D-glucosaminidase–a marker of tubular damage? Nephrology Dialysis Transplantation. 1999;14:620-626.

[23] Salem MA, el-Habashy SA, Saeid OM, et al. Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus. Pediatric Diabetes. 2002;3:37-41.

[24] Katagiri D, Doi K, Honda K, et al. Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery. Ann Thorac Surg. 2012;93:577-583.

[25] Fu W, Xiong S, Fang Y, et al. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine. 2012;41:82-88.

[26] Zhou X, Ma B, Lin Z, et al. Evaluation of the Usefulness of Novel Biomarkers for Drug-Induced Acute Kidney Injury in Beagle Dogs. Toxicol Appl Pharmacol. 2014;280:30-35.

[27] Zhang Y, Qiao S, Wang R, et al. NGAL Attenuates Renal is-chemia/reperfusion Injury Through Autophagy Activation and Apoptosis Inhibition in Rats. Chem Biol Interact. 2018;289:40-46.

[28] Kari JA, Shalaby MA, Sofyani K, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) and serum cystatin C measurements for early diagnosis of acute kidney injury in children admitted to PICU. World J Pediatr. 2018;14:134-142.

[29] Lavery AP, Meinzen-Derr J K, Anderson E, et al. Urinary NGAL in Premature Infants. Pediatr Res. 2008;64: 423-428.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time